CYNTHIA M BUTITTA
CIK 1222082 · Chief Operating Officer · last filed 2025-12-01
CYNTHIA M BUTITTA is a Chief Operating Officer who has filed 61 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for URGN, was dated Dec 1, 2025. Across all open-market trades the lifetime net is −$25.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $887.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$887.3K
5
61
-$25.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| URGN | Director | 2,000 | $29.72 | $59.4K | $0 | 8 | 2025-12-01 |
| IPSC | Director | — | $2.25 | — | $0 | 5 | 2025-06-16 |
| OLMA | Director | 83,876 | $9.87 | $827.9K | $0 | 7 | 2025-06-13 |
| Kite Pharma, Inc. (KITE) Delisted | Chief Operating Officer | 121,567 | — | — | -$25.78M | 38 | 2017-09-27 |
| MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | COO and CFO | — | — | — | $0 | 2 | 2009-11-18 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-01 | URGN | Exer (M) | +2,000 | $0 | EDGAR |
| 2025-08-27 | URGN | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2024-08-08 | URGN | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2023-09-08 | URGN | Grant (A) | — | $0 | EDGAR |
| 2023-06-29 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2023-06-21 | OLMA | Grant (A) | — | $0 | EDGAR |